Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries

Articles published by PCI Pharma Services

PCI Pharma Services to Acquire US-based Aseptic Fill-Finish CDMO Ajinomoto Althea
From PCI Pharma Services
Via Business Wire
PCI Pharma Services Invests Over $365 Million in EU, US Facilities for Clinical and Commercial Supply of Advanced Drug Delivery and Drug-Device Combination Products
From PCI Pharma Services
Via Business Wire
PCI Pharma Services’ Bedford, New Hampshire Location Successfully Completes International Coalition of Medicines Regulatory Authorities Inspection
From PCI Pharma Services
Via Business Wire
Leading CDMO PCI Pharma Services Releases Inaugural Comprehensive ESG Report
From PCI Pharma Services
Via Business Wire
Aldena Therapeutics Selects PCI Pharma Services to Manufacture and Distribute Innovative Investigational Treatment for Dermatological Diseases
From PCI Pharma Services
Via Business Wire
PCI Pharma Services Announces New Sterile Fill-Finish Capabilities Now Available in Melbourne and San Diego
From PCI Pharma Services
Via Business Wire
PCI Pharma Services Expands Biologics Leadership with new Center of Excellence Facility in the Midwest
From PCI Pharma Services
Via Business Wire
PCI Pharma Services Opens New England Center of Excellence to Bring Global Clinical Supply Capabilities to New England
From PCI Pharma Services
Via Business Wire
PCI Pharma Services Announces Multi-Million Dollar Expansion to UK Manufacturing Facility to Meet Growing Demand for Global High Potent Manufacturing Services Supporting Oncology Treatments
From PCI Pharma Services
Via Business Wire
PCI Pharma Services Announces Major Manufacturing Expansion with $100 Million Investment in New England, Providing Global Capacity to Clients
From PCI Pharma Services
Via Business Wire
Following LSNE Acquisition, PCI Pharma Services Continues to Expand Sterile Fill-Finish Expertise with State-of-the-Art Equipment
From PCI Pharma Services
Via Business Wire
PCI Pharma Services Announces the Acquisition of LSNE to Add End-To-End Global Sterile Fill-Finish and Lyophilization Manufacturing Capabilities
From PCI Pharma Services
Via Business Wire
John Cullivan Joins PCI Pharma Services as Chief Corporate Development Officer
From PCI Pharma Services
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.